T‐cell homeostasis in chronic HCV‐infected patients treated with interferon and ribavirin or an interferon‐free regimen

By  

APMIS (ELECTRONIC), Vol. 903-4641, Iss. 10, 2015-10 ,pp. : 903-911

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 1, 2015-01 ,pp. : 25-36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

By Garib Junia Rios   Garcia Guilherme Freire   Teixeira Rosâângela   Lima e Silva Francisco das Chagas  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 8, 2011-08 ,pp. : 625-631

Informa Healthcare

Access to resources Recommend Favorite

Interleukin 6 and 12, Alanine Aminotransferase Activity, and HCV Viral Load in Children with Chronic Hepatitis C Treated with Interferon and Ribavirin

By Kowala-Piaskowska Arleta   Mozer-Lisewska Iwona   Figlerowicz Magdalena   Machowska Ludomiła   Służewski Wojciech  

Inflammation, Vol. 28, Iss. 6, 2004-12 ,pp. : 319-325

Springer Publishing Company

Access to resources Recommend Favorite

Interferon‐free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND‐C3, a Phase 2b study

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 417-421

John Wiley & Sons Inc

Access to resources Recommend Favorite